We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool

    Purpose

    The standard follow-up for non-muscle-invasive bladder cancer is based on cystoscopy. Unfortunately, post-instillation inflammatory changes...

    Clément Klein, Serge Brunelle, ... Geraldine Pignot in World Journal of Urology
    Article 20 March 2024
  2. Clinical trial design for non-muscle-invasive bladder cancer

    Wei Shen Tan, Emma Hall, ... John D. Kelly in Nature Reviews Urology
    Article 16 June 2023
  3. Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters

    Purpose

    A prevalent condition with a high probability of recurrence, non-muscle invasive bladder cancer (NMIBC) necessitates lifetime surveillance. In...

    Yi He, Chenxi Pan, ... Bo Yang in BMC Urology
    Article Open access 25 March 2024
  4. Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

    Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into the detrusor muscle layer. Transurethral resection of...

    Jeremy Yuen-Chun Teoh, Ashish M. Kamat, ... Marek Babjuk in Nature Reviews Urology
    Article 31 March 2022
  5. Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study

    Purpose

    The Geriatric Nutrition Risk Index (GNRI) is a simple and validated tool used to assess the nutritional status of elderly patients and predict...

    **gxin Wu, **aofeng Cheng, ... Gongxian Wang in International Urology and Nephrology
    Article 04 January 2024
  6. Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols

    Introduction

    The combination of sequential intravesical gemcitabine and docetaxel (Gem/Doce) chemotherapy has been considered a feasible option for...

    Reuben Ben-David, Neeraja Tillu, ... John P. Sfakianos in World Journal of Urology
    Article 11 May 2024
  7. Pre-therapeutic lymphocytopenia: a new prognostic factor for failure of endovesical BCG-immunotherapy in non-muscle invasive bladder cancer

    Background

    Inflammation plays a key role in the initiation and development of cancers. The prognostic value of inflammation biomarkers is proven in...

    Idriss Ziani, Ahmed Ibrahimi, ... Amal Bouziane in African Journal of Urology
    Article Open access 29 March 2023
  8. Potential influence of anaesthesia techniques on the recurrence and progression after resection of non-muscle-invasive bladder cancer: a propensity score-matched analysis

    Background

    The non-muscle-invasive bladder cancer is a common malignancy of the urinary system. Many patients relapse after transurethral resection...

    Ruifeng Xue, Chongxi Zhao, ... Qiang Li in BMC Anesthesiology
    Article Open access 18 August 2022
  9. Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer

    Background

    Trans-Urethral Resection of Bladder Tumors (TURBT) is a critical step in diagnosis, staging and treatment of bladder tumors. Conventional...

    Ahmed Assem, Ayman Kassem, ... Mohamed Abdelwahed in International Urology and Nephrology
    Article Open access 28 August 2023
  10. The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis

    Objectives

    Although smoking is a well-recognized causative factor of urothelial bladder cancer and accounts for 50% of cases, less is known about the...

    Aleksander Ślusarczyk, Piotr Zapała, ... Piotr Radziszewski in Journal of Cancer Research and Clinical Oncology
    Article Open access 21 November 2022
  11. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)

    Non-muscle invasive bladder cancer (NMIBC) is a major type of bladder cancer with a high incidence worldwide, resulting in a great disease burden....

    Ying-Hui **, **an-Tao Zeng, ... **ng-Huan Wang in Military Medical Research
    Article Open access 17 August 2022
  12. Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study

    Background

    This study aimed to characterize the urinary and tumor microbiomes in patients with non-muscle-invasive bladder cancer (NMIBC) before and...

    Aleksander Ślusarczyk, Hamza Ismail, ... Piotr Radziszewski in Annals of Surgical Oncology
    Article 03 April 2024
  13. A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

    Background

    Currently, the clinical strategy for diagnosis of non-muscle invasive bladder cancer (NMIBC) such as cystoscopy and cytology are invasive...

    Hai Huang, Ao Liu, ... Yi Gao in BMC Medicine
    Article Open access 19 September 2023
  14. Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer

    Purpose

    Bladder cancer represents 3% of all new cancer diagnoses per year. We propose intravesical radionuclide therapy using the β-emitter 90 Y...

    Alessandra Alì, Dev Leibowitz, ... Andrei Molotkov in European Journal of Nuclear Medicine and Molecular Imaging
    Article 09 November 2022
  15. Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer

    High-grade non-muscle-invasive bladder cancer (HG NMIBC) patients are at high risk (HR) of progression to muscle-invasion. Bladder-preserving...

    Stefan Garczyk, Stephan Degener, ... Ruth Knüchel in Virchows Archiv
    Article Open access 28 April 2022
  16. Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis

    Purpose

    To evaluate the efficacy of repeat transurethral resection on restaging, preventing tumor recurrence and progression in high-risk non-muscle...

    Mengqi Zhou, Binrui Yang, ... Henglong Hu in Journal of Cancer Research and Clinical Oncology
    Article 31 December 2022
  17. The natural history of low-risk non-muscle-invasive bladder cancer: a collaborative multi-centre study

    Background

    International guidelines vary in terms of their definition and recommendation for management of low-risk non-muscle-invasive bladder cancer...

    A. Jaffer, M. Lee, ... S. R. JainChahal in International Urology and Nephrology
    Article 27 June 2022
  18. Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer

    Purpose

    To investigate whether preoperative CT features can be used to predict risk stratification of non-muscle invasive bladder cancer (NMIBC).

    ...
    Li Chen, Gumuyang Zhang, ... Hao Sun in Abdominal Radiology
    Article 01 December 2022
  19. Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage

    Non-muscle-invasive bladder cancer (NMIBC) represents a significant global therapeutic challenge, particularly in the era of Bacillus Calmette–Guérin...

    Adithya Balasubramanian, Ashray Gunjur, ... Marlon Perera in World Journal of Urology
    Article 27 January 2022
  20. Role of plasma fibrinogen and D-dimer as prognostic biomarkers in patients with non-muscle invasive bladder cancer

    Background

    We aimed to evaluate the role of plasma fibrinogen and D-dimer as prognostic biomarkers in patients with non-muscle invasive bladder cancer...

    Sahil Singla, Apul Goel, ... Sashi Raj Singh in African Journal of Urology
    Article Open access 30 March 2023
Did you find what you were looking for? Share feedback.